This systematic review examined the evidence on the prevalence of the Hepatitis C Virus
(HCV) in non-injecting drug users (NIDUs) who sniff, smoke or snort drugs such as heroin …

OBJECTIVES: Injection drug use (IDU) is the predominant mode of hepatitis C virus (HCV)
transmission in China. This paper aims to provide a comprehensive and reliable tabulation …

The authors examined the relation between time since onset of illicit drug injection (time at
risk) and rates of hepatitis C virus (HCV) infection by using meta-regression. In 72 …

Chronic hepatitis C is the most common infectious disease among injection drug users
(IDUs). Because of the allegedly poor compliance of IDUs with treatment requirements and …

With the development of new highly efficacious direct‐acting antiviral (DAA) treatments for
hepatitis C virus (HCV), the concept of treatment as prevention is gaining credence. To date …

Background: Beginning in 1994, Vancouver experienced an explosive outbreak of HIV
infection among injection drug users (IDUs). The objectives of this study were to measure …

This study examines how Chinese drug regulations are shifting illicit fentanyl production
from China to India. This change has implications for the law, drug enforcement …

Early acquisition of hepatitis C virus (HCV) infection appears to affect a substantial
proportion of injection drug users (IDUs)—between 20 percent and 90 percent. Analysing …

Ten years after the first seroprevalence study performed in Flanders, the aim of this cross
sectional study was to follow the evolution of hepatitis A, B and C prevalence. The …

Currently, the most important risk factor for hepatitis C virus (HCV) infection in Europe is
intravenous drug use. To establish a better insight into the epidemiology of hepatitis C …